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Abstract 
 
Objective: This study aimed to examine the extent to which illness perceptions and  
coping strategies among women diagnosed with breast cancer explain psychological 
distress at diagnosis and at six months post-diagnosis relative to demographic and 
illness-related variables.  
Methods: Women were recruited to the study shortly after diagnosis. A total of 90 
women completed study materials (Illness Perception Questionnaire-Revised, the 
Cancer Coping Questionnaire and the Hospital Anxiety and Depression Scale) at time 
1. The same questionnaires were sent approximately six months later to those who had 
consented at time 1, and completed questionnaires were returned by 72 women. 
Results: Cluster analysis was used to identify groups of respondents who reported a 
similar profile of illness perception scores. Regression analysis demonstrated that one 
of these clusters was more likely to experience psychological distress than the other 
both at diagnosis and at six months post-diagnosis. Illness perceptions cluster 
membership and positive focus type coping were the most important and consistent 
predictors of lower psychological distress at diagnosis and at six months post-
diagnosis. Conclusions: Illness perceptions remained relatively stable over the study 
period, and therefore we are unable to clarify whether changes in illness cognitions are 
associated with a corresponding change in psychological symptoms. Future research 
should evaluate the impact on psychological distress of interventions specifically 
designed to modify illness cognitions among women with breast cancer. 
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Introduction 
  
 There is a growing interest in the role of cognitive factors in the experience of 
distress [1] among people with cancer. Previous research suggests that a useful model 
in helping to clarify the interrelationships between cognitive factors and various health 
outcomes is Leventhal’s Self-Regulatory Model (SRM) [2]. The SRM proposes that in 
order to make sense of and cope with their illness, individuals construct internal 
representations of their illness, which have both cognitive and emotional content. 
These representations relate to thoughts about, for example, the causes, consequences 
and timeline of the illness, the ability to control the illness and worries and fears about 
the illness. These representations lead to the generation of coping responses. The 
individual will then assess whether their chosen coping strategies have been effective 
(known as the appraisal process) and this may result in the modification of the 
representations or coping strategies adopted [3,4]. There is a growing body of research 
evidencing strong relationships between illness cognitions and health outcomes, both 
physical and psychological [5-10]. 
 Previous research in the area of oncology has already demonstrated strong 
relationships between illness cognitions and psychological distress. For example, even 
after controlling for disease related variables, illness cognitions were shown to explain 
a significant proportion of the variance in psychological distress in breast cancer [6,9], 
head and neck cancer [7,8] and localized prostate cancer [10]. Much of the research in 
this area to date has been cross-sectional, and hence the utility of illness cognitions in 
predicting longitudinal psychological outcomes is still unclear due to the limited 
number of studies utilising a longitudinal design and also a lack of consistency among 
findings across these studies [6,8,11]. This lack of consistency may exist because the 
nature of the longitudinal relationship between illness cognitions and health outcomes 
is population-specific. Therefore, caution needs to be exercised when extrapolating 
findings from other populations to breast cancer. The previous longitudinal research 
conducted among women with breast cancer did not obtain an assessment of illness 
perceptions and distress prior to surgical treatment and they used the Illness 
Perceptions Questionnaire, which has now been modified and improved[6]. 
Accordingly, our knowledge about the changes in illness perceptions and 
psychological distress among women with breast cancer, from the point of diagnosis 
onwards is limited. 
 A central tenet of the SRM is that the relationship between illness cognitions 
and psychological health outcomes are mediated by an individual’s coping responses. 
There is, however, a lack of evidence to support this hypothesis [9,12,13]. One 
potential explanation for the weak relation between coping and perceived 
psychological health outcomes may be due to the use of generic measures of coping in 
previous studies [9] as they do not measure specific coping behaviours, but more 
generalized coping styles.  Hence, research using more robust domain-specific 
assessments of coping is needed to better clarify the role of coping and its potential 
mediation between illness representations and psychological outcomes. 
 The evidence of relationships between illness cognitions and psychological 
distress demonstrated in previous research is promising, and points the way for the 
development of a psychological intervention for women diagnosed with breast cancer 
which is based on the modification of these cognitions. However, prior to the 
development of such an intervention it is important that we clarify the longitudinal 
relationships between illness cognitions, coping and psychological distress among 
women with breast cancer, and the types of cognitions that are associated with higher 
levels of distress within this population. 
 The current study seeks to clarify the relationship between illness perceptions, 
coping and psychological distress (anxiety and depression) at diagnosis among women 
diagnosed with breast cancer using a domain-specific assessment of coping, and to 
investigate whether illness perceptions and coping at diagnosis predicts psychological 
distress (anxiety and depression) at 6 months post-diagnosis. 
   
Method 
 
 Participants were recruited from a hospital breast care clinic, approximately one 
to two weeks following a diagnosis of breast cancer. Women who were over the age of 
18 years with a new diagnosis of breast cancer were invited to participate. Women 
were excluded from participation if they were identified from their notes as having a 
previous cancer. Those women who returned a completed consent form and study 
questionnaires at diagnosis were then sent further study questionnaires at six months 
post-diagnosis. 
 Participants were asked to complete a questionnaire booklet containing items 
relating to demographic information (age, living arrangements, number of dependents 
and whether they had previously accessed psychological support services) and the 
following questionnaires: 
 Illness Perception Questionnaire – Revised (IPQ-R) [14]. This questionnaire 
was used to assess the following illness cognitions: identity, timeline acute/chronic, 
timeline cyclical, personal control, treatment control, consequences, cause and illness 
coherence. Higher scores on the identity scale indicate that that the person associates a 
greater number of symptoms with the cancer. Higher scores on the personal control 
and treatment control scales indicate that the person has a stronger belief in the 
effectiveness of their ability or the treatment to control the symptoms of cancer. Higher 
scores on the consequences scale suggests that the person perceives more severe 
consequences of cancer. Higher scores on the illness coherence scale indicate that the 
person has a clearer understanding of the condition. Higher scores on the timeline 
acute/chronic and timeline cyclical scales indicate a stronger belief that the condition is 
chronic (rather than acute) and goes through cycles of getting better and worse rather 
than remaining stable.  
 The factor structure of the IPQ-R has been confirmed in previous research in a 
range of conditions, including cancer populations [15]. This previous research has not 
examined the factor structure of the 18 items which measure perceptions of cause of 
illness, as the authors of the IPQ-R suggest that the cause items should be factor 
analysed for each sample. Therefore, in the present research the 18 cause items were 
factor analysed and were found to load on three factors, which were labelled emotional 
causes (e.g. stress or worry), behavioural causes (e.g. smoking or alcohol use) and 
externalised causes (e.g. hereditary or a virus). Higher scores on the cause subscales 
indicate a stronger belief that this was a cause of the breast cancer. The above factor 
solution is consistent with previous research [9,16], which also found a three factor 
solution. The IPQ-R has sound psychometric properties, with evidence for construct, 
discriminant and predictive validity and for internal and test-retest reliability [14]. 
 The Cancer Coping Questionnaire (CCQ) [17]. The CCQ is a brief, 21 item 
self-rating scale designed to assess coping strategies across the following five 
dimensions: reflection/relaxation coping; positive focus; diversion; planning; and use 
of interpersonal support.  Higher scores on each scale indicate that this coping strategy 
is used more often.  The CCQ is therefore an example of a domain-specific coping 
measure, and has been found to have good reliability and validity [17]. 
 The Hospital Anxiety and Depression Scale (HADS) [18]. This is a 14 item 
scale which is divided into two dimensions – anxiety and depression. Higher scores 
represent higher levels of anxiety and depression. Scores for the anxiety dimension and 
the depression dimension can be categorised as follows: 0-7: normal, 8-10: mild, 11-
14: moderate, 15-21: severe, with scores of eight or more indicating potentially 
problematic levels of distress [19]. The HADS has been validated among a population 
of people with cancer [20] and is the most frequently used screening tool for 
psychological distress in cancer care [21].  
 Participant’s clinical and treatment related details (tumour grade, nodal status, 
surgery, and treatment received) were later retrieved from medical notes. The research 
was approved by the local Research Ethics Committee. 
 
Statistical Analysis  
 To address the study aim, four hierarchical regression analyses were conducted 
- one for each outcome (anxiety and depression) at each point in time. Medical and 
demographic variables were entered into the regression models in block one; illness 
perception clusters (from time 1) were entered in block two; and the coping variables 
(from time 1) were entered in block three. In this way, we were able to determine the 
additional contribution to the explanation of variance in the outcome variable made by 
each block of variables. Additionally, this strategy allowed us to examine whether the 
addition of the coping variables changed the regression coefficients of the illness 
perception variables. If so, this would suggest that coping variables could be playing a 
mediating role in the model and would highlight the need for further analyses to 
explore this potential mediation.  
 Prior to being entered into the regression analyses, the illness perceptions 
scores at time 1 were subjected to cluster analysis. Cluster analysis is a statistical 
method for identifying people who have a similar pattern of scores across a series of 
variables. Consequently, the cluster analysis in this study provided an indication of 
people who share a similar pattern of illness cognitions. A two stage cluster analysis 
was conducted. Initially, all scores were converted to Z scores and Ward’s clustering 
method was used to identify the number of clusters. A k-means analysis was then 
conducted using the number of clusters and the centroids identified by Ward’s method. 
The squared Euclidean distance was the proximity measure chosen. On the basis of the 
dendrogram and the agglomeration schedule, two clusters were considered to be the 
optimum solution. 
 
Results 
 
 A total of 90/172 women were recruited to the study (52.3% recruitment rate) 
and returned completed questionnaires at time 1. Questionnaire responses at time 2 (6 
months post-diagnosis) were returned by 75 women (16.67% attrition rate). Summary 
statistics for demographic and clinical characteristics are presented in Table 1.  
- Table 1 here – 
 
 Analysis (t-tests and chi-square analysis) revealed no significant differences 
between those participants who provided data at time point 2 and those who did not on 
any of the demographic or clinical variables presented in Table 1, or on the illness 
perception, anxiety and depression scores. 
 Table 2 provides the centroids for the two clusters in the cluster analysis for 
illness cognition variables. The centroids suggest that respondents in cluster 1 have less 
positive cognitions about their cancer. Specifically they have cognitions that the illness 
has a more chronic and cyclical timeline, more severe consequences, and associate 
more symptoms with the illness than respondents in cluster 2. Respondents in cluster 1 
have perceptions of both lower personal and treatment control, and a less coherent 
understanding of the illness. They also endorse causal attributions more strongly than 
respondents in cluster 2, having greater perceptions of emotional, behavioural, and 
externalised causes. 
- Table 2 here - 
 
 Descriptive statistics for the two time points and the results of paired t-tests to 
examine the change over time on all IPQ-R and HADS subscales are presented in 
Table 3. Most of the illness perception variables remained stable across time, and any 
that changed significantly had a small effect size.  
 A significant improvement across time was found for anxiety scores. There was 
no significant change in depression scores. 
- Table 3 here - 
 
 To examine the relationship between illness cognitions, coping, and 
psychological distress at diagnosis, and at six months post diagnosis we conducted a 
series of hierarchical regression analyses for each outcome variable (anxiety and 
depression) at each time point, with demographic and clinical variables, illness 
perceptions cluster membership, and coping scores entered as separate blocks.  
The regression models specified in Table 4 explained 39.2% of the variance in 
symptoms of anxiety (F(16,63) = 4.185, p < .001) at diagnosis, and 25.2% of the 
variance in symptoms of anxiety (F(16,49) = 2.367, p = .011) at six months post-
diagnosis. The clinical and demographic variables contributed less than 5% of the 
variance explained at diagnosis (2.5% at six months) and the illness perceptions cluster 
membership contributed an additional 24.6% at diagnosis (9.5% at six months), with 
the coping variables contributing the remaining 10% at diagnosis (13.2% at six 
months).  
 Women with a pattern of illness cognitions represented by cluster 2 had lower 
levels of anxiety at both time points than women in cluster 1 and as their use of a 
positive focus coping strategy increased, the reported anxiety levels at both points in 
time decreased. At six months post-diagnosis, anxiety levels increased in line with 
reports of increasing adoption of the reflection/relaxation coping strategy. 
- Table 4 here - 
 
 The regression models specified in Table 5 explained 36.1% of the variance in 
symptoms of depression (F(16,63) = 3.792, p < .001) at diagnosis, and 17.1% of the 
variance in symptoms of depression (F(16,49) = 1.837, p = .053) at six months post-
diagnosis. At diagnosis, the demographic and clinical variables contributed 2.6% of the 
variance explained (1.3% at 6 months) and the illness perceptions cluster membership 
contributed an additional 20.5% (11.3% at six months), with the coping variables 
contributing the remaining 13% (4.4% at six months).  
 As with the anxiety outcome, women with a pattern of illness cognitions 
represented by cluster 2 had lower levels of depression at both time points than women 
in cluster 1 and as their use of a positive focus coping strategy increased, the reported 
depression levels at time 1 decreased. Furthermore, Table 5 indicates that women who 
had a spouse/partner showed lower levels of depression at both time points than 
women who did not have a spouse/partner. At six months post-diagnosis, depression 
levels increased in line with reports of increasing adoption of the reflection/relaxation 
coping strategy. 
 There was no evidence of a mediating role for coping in the relationship 
between illness perceptions and depression or anxiety at either time-point. 
- Table 5 here – 
 
Discussion 
.  
  Overall psychological wellbeing within the sample was within the ‘normal’ 
range for depression scores and within the ‘potentially problematic’ range for anxiety 
scores (according to the HADS categorisations), with anxiety scores decreasing over 
time. There is, however, a subgroup of women with ‘problematic’ anxiety (34.7%) and 
depression (15.3%) at six months post-diagnosis. Similar results, highlighting an ‘at 
risk’ subgroup have been reported among breast cancer patients [22], and within a 
sample of patients with breast, prostate, and bronchial cancers [23]. Therefore, there is 
a need to explore methods of alleviating the psychological distress of this subgroup of 
women. 
 Our findings highlight the role that illness cognitions and coping play in the 
psychological distress of women with breast cancer and these are areas which might 
lend themselves to modification via intervention to improve psychological wellbeing, 
particularly for women in the ‘at risk’ category. More specifically, we have identified a 
particular pattern of illness cognitions that is associated with lower levels of 
psychological distress. It appears that women report lower levels of distress when they 
believe that their breast cancer will not last a long time and will not be cyclical in 
nature; when they believe that their treatment will be effective; when they do not 
believe that their cancer will have serious consequences for their life and when they do 
not have particularly strong beliefs about the cause of their breast cancer. Women who 
engage in a positive coping strategy also report lower levels of distress. In summary, 
on the basis of our findings, an intervention designed to minimise psychological 
distress among women with breast cancer should focus on enhancing these positive 
cognitions. An example of a potentially useful intervention is the positive self-talk 
approach [24,25]. 
However, it is important to note that there was little meaningful change in 
illness perceptions over time. This is in contrast to predictions of the SRM, and has 
important implications for psychological intervention in this population. Most 
significantly, this means that this study could provide no evidence about the effect on 
psychological distress among women with breast cancer, if illness perceptions changed 
over time. Although changes in illness perceptions across time have been noted in 
previous research among people with back pain [26] and osteoarthritis [27,28], 
previous longitudinal research conducted among people with cancer has also shown  
that illness perceptions remain stable over time [6,29]. 
Our results among women with breast cancer suggest that illness perceptions 
within this population are resistant to change (at least within the timeframe of this 
study) without directed intervention aimed specifically at modifying them. Therefore, 
future research in this area needs to set out to purposefully change illness perceptions 
in order to determine whether this manufactured change will have a resultant change 
on levels of psychological distress. If the findings from this type of research 
demonstrated that psychological health outcomes changed in line with changes in 
illness perceptions, this would further strengthen the case for an illness perceptions 
based intervention to alleviate psychological distress among women with breast cancer. 
 The present study also highlights some theoretical implications. Primarily, there 
was no evidence that coping had a mediating role in the relationship between illness 
perceptions and psychological distress. These results are in contrast with the SRM but 
are consistent with previous research that also failed to demonstrate a mediating role 
for coping [9,12,13,16]. The current study employed a more domain specific measure 
of coping than the generic measures used in previous studies, and hence provides no 
support for the explanation offered by Rozema et al. [9] for the weak relation between 
coping and outcome. An alternative explanation for the failure to detect a mediating 
effect of coping may be the nature by which illness perceptions are assessed. Given the 
complexity of illness perceptions and the appraisal process suggested by the SRM, it is 
difficult to ascertain exactly what a participant’s responses to IPQ-R items are 
capturing. It is possible that responses to the IPQ-R are not simply reflecting illness 
perceptions, but are informed by the respondent’s appraisal of their ability to cope. For 
example, a ‘disagree’ response to an item such as ‘The consequences of this illness are 
severe’ may reflect an individual’s appraisal of their ability to cope with severe 
physical, social, and economic consequences imposed by the illness via the utilization 
of support networks available to them. 
 Although the response rate in this study is considerably higher than what is 
usual for a postal questionnaire study, 47.7% of the women who were approached 
declined to participate. This limits the generalisability of the study findings, as there is 
no way of knowing whether there was any bias in the sample. For example, it might be 
the case that distress is under-estimated in the current study as women who are 
experiencing high levels of distress might not wish to participate in research. However, 
there is no way of substantiating or refuting this assumption, and the levels of 
psychological distress reported by women in this study are similar to that reported by 
women in previous research in breast cancer. 
 
Conclusions 
 Previous research which has evaluated interventions designed to modify illness 
perceptions has shown improvements in health-related outcomes among people who 
have experienced a myocardial infarction [30] and among those with Type 2 diabetes 
[31]. However, the effectiveness of illness perceptions based interventions in the 
improvement of psychological distress among cancer survivors has not yet been 
demonstrated. Future research should evaluate the impact of interventions specifically 
designed to modify illness cognitions among women with breast cancer, since illness 
perceptions among this population appear to be fairly resistant to change (without 
direct intervention) over the early course of the illness experience and treatment. 
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Table 1: Participants’ demographic and clinical characteristics 
 
 Time 1 Time 2 
Mean age (SD) 57.2 (10.4) 56.8 (9.7) 
 N (%) N (%) 
Dependents at home 
Yes 
No 
 
20 (22.2) 
70 (77.8) 
 
17 (22.7) 
58 (77.3) 
Carer role 
Yes 
No 
Missing 
 
27 (30.0) 
62 (68.9) 
1 (1.1) 
 
24 (32.0) 
61 (68.0) 
Living arrangements 
Single 
Married / Cohabitating 
Widowed / Divorced 
 
10 (11.1) 
64 (71.1) 
16 (17.8) 
 
8 (10.7) 
55 (73.3) 
12 (16.0) 
Previous psychological services 
Yes 
No 
Missing 
 
22 (24.4) 
67 (74.4) 
1 (1.1) 
 
18 (24.0) 
56 (74.7) 
1 (1.3) 
Grade of tumour 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
Unknown 
 
7 (7.8) 
14 (15.6) 
33 (36.7) 
35 (38.9) 
1 (1.1) 
 
5 (6.7) 
11 (14.7) 
29 (38.7) 
29 (38.7) 
1 (1.3) 
Nodal status 
Positive 
Negative 
 
26 (28.9) 
64 (71.1) 
 
23 (30.7) 
52 (69.3) 
Treatment 
Chemotherapy 
No chemotherapy 
Missing 
 
47 (52.2) 
41 (45.6) 
2 (2.2) 
 
40 (53.3) 
34 (45.3) 
1 (1.3) 
Surgery 
Partial mastectomy 
Full mastectomy* 
Missing 
 
57 (56.7) 
38 (42.2) 
1 (1.1) 
 
44 (58.7) 
30 (40.0) 
1 (1.3) 
* with or without reconstruction 
 
 
 
 
 
 
Table 2: Cluster Centroids for Illness Perceptions Clusters 
 
 Scale midpoint Cluster 1 (n=55) 
Mean (SD) 
Cluster 2 (n=32) 
Mean (SD) 
IPQ Acute/chronic timeline 18 17.52 (3.65) 12.63 (3.75) 
IPQ Cyclical timeline 14 12.78 (2.26) 9.69 (2.83) 
IPQ Treatment control 15 19.25 (1.90) 21.88 (2.27) 
IPQ Emotional cause 15 16.83 (4.01) 10.22 (4.20) 
IPQ Behavioural cause 12 11.61 (2.90) 7.67 (2.49) 
IPQ Externalised cause 12 16.76 (3.07) 11.93 (4.74) 
IPQ Consequences 18 21.71 (3.48) 16.28 (3.21) 
IPQ Personal control 18 19.55 (3.48) 21.06 (4.44) 
IPQ Illness coherence 15 17.04 (3.75) 18.87 (4.30) 
IPQ Identity 7.5 4.33 (3.09) 1.78 (2.42) 
 
 
Table 3: Change over time in IPQ and HADS subscale scores 
 
 Potential 
Midpoint 
Time 1 
Mean 
(SD) 
Time 2 
Mean 
(SD) 
t p Effect 
size* 
HADS Anxiety  10.5 8.67 
(4.84) 
5.99 
(4.44) 
5.753 <.001 0.68 
HADS Depression  10.5 4.01 
(4.21) 
3.99 
(3.59) 
.059 .953 0.01 
IPQ Acute/chronic timeline 18 15.75 
(4.47) 
15.43 
(5.00) 
.566 .573 0.07 
IPQ Cyclical timeline 14 11.42 
(2.94) 
10.96 
(3.05) 
1.167 .247 0.14 
IPQ Treatment control 15 20.41 
(2.47) 
19.59 
(2.62) 
2.404 .019 0.29 
IPQ Emotional cause 15 14.40 
(5.21) 
14.92 
(5.41) 
1.036 .304 0.12 
IPQ Behavioural cause 12 10.05 
(3.32) 
11.28 
(3.73) 
3.204 .002 0.38 
IPQ Externalised cause 12 14.73 
(4.20) 
15.72 
(3.79) 
2.204 .031 0.26 
IPQ Consequences 18 19.81 
(4.16) 
19.81 
(4.49) 
0.033 .973 0.003 
IPQ Personal control 18 20.10 
(4.13) 
19.08 
(4.09) 
1.887 .063 0.22 
IPQ Illness coherence 15 17.83 
(4.03) 
18.17 
(3.40) 
0.761 .449 0.09 
IPQ Identity 7.5 3.32 
(3.07) 
4.12 
(3.57) 
2.077 .042 0.25 
 
* Effect size = mean difference divided by SD of difference scores 
 
 
 
 
 
 
 
 
 
Table 4: Regression analyses with symptoms of anxiety at diagnosis and 6 months post-diagnosis 
as the outcome variables 
 
* b = Unstandardised regression coefficient  Beta = Standardised regression coefficient 
 
 
 
 
 
 
 
 
 
 At diagnosis 6 months post-diagnosis 
  b* Beta* t p b* Beta* t p 
Block 1         
Treatment  
(0=no chemo; 1=chemo) 
.524 .052 .341 .734 -.501 -.055 -.304 .762 
Living arrangements 
(0=not in; 1=in relationship) 
-1.670 -.147 -1.448 .153 -2.593 -.241 -1.796 .079 
Nodal status  
(0=negative; 1=positive) 
-1.136 -.104 -.994 .324 .146 .015 .117 .908 
Surgery  
(0=partial; 1=full mastectomy) 
.193 .019 .197 .845 .928 .101 .818 .418 
Dependents  
(0=no; 1=yes) 
2.397 .196 1.751 .085 .349 .032 .235 .815 
Carer  
(0=no; 1=yes) 
.090 .008 .080 .936 .140 .014 .112 .911 
Previous psych services 
(0=no; 1=yes) 
.145 .013 .129 .898 1.427 .138 1.109 .273 
Age 
 
-.063 -.129 -1.162 .249 .047 .096 .729 .469 
Tumour grade 3 vs 0 
 
2.023 .114 .956 .343 1.146 .067 .462 .646 
Tumour grade 3 vs 1 
 
3.081 .227 1.573 .121 1.258 .100 .580 .565 
Tumour grade 3 vs 2 
 
.087 .008 .068 .946 1.210 .131 .902 .372 
Block 2         
Cognitions cluster  
(1 vs 2) 
-4.345 -.418 -4.288 <.001 -2.323 -.250 -2.100 .041 
Block 3         
CCQ Reflect/relaxation 
 
.419 .275 1.977 .052 .619 .451 2.660 .011 
CCQ Positive focus 
 
-.626 -.302 -2.549 .013 -.765 -.429 -2.870 .006 
CCQ Diversion 
 
.371 .183 1.400 .166 -.042 -.024 -.140 .889 
CCQ Planning 
 
-.154 -.073 -.634 .528 .069 .038 .259 .797 
Constant 17.077  3.720 <.001 5.530  1.095 .279 
  
Table 5: Regression analyses with symptoms of depression at diagnosis and 6 months post-
diagnosis as the outcome variables 
 
*b = Unstandardised regression coefficient  Beta = Standardised regression coefficient 
 
 
 
 At diagnosis 6 months post-diagnosis 
  b* Beta* t p b* Beta* t p 
Block 1         
Treatment  
(0=no chemo; 1=chemo) 
-.810 -.105 -.665 .508 -.041 -.006 -.030 .976 
Living arrangements 
(0=not in; 1=in relationship) 
-1.909 -.217 -2.088 .041 -2.636 -.304 -2.156 .036 
Nodal status  
(0=negative; 1=positive) 
-1.407 -.167 -1.554 .125 .122 .016 .116 .908 
Surgery  
(0=partial; 1=full mastectomy) 
1.181 .150 1.516 .135 .194 .026 .202 .841 
Dependents  
(0=no; 1=yes) 
1.637 .173 1.509 .136 .619 .071 .492 .625 
Carer  
(0=no; 1=yes) 
.600 .070 .673 .504 1.116 .141 1.057 .296 
Previous psych services 
(0=no; 1=yes) 
-.920 -.103 -1.032 .306 .748 .090 .687 .495 
Age 
 
-.066 -.173 -1.515 .135 .027 .069 .499 .620 
Tumour grade 3 vs 0 
 
-1.318 -.096 -.787 .434 -.589 -.043 -.281 .780 
Tumour grade 3 vs 1 
 
1.291 .123 .831 .409 .049 .005 .027 .979 
Tumour grade 3 vs 2 
 
-.205 -.026 -.203 .840 .597 .080 .525 .602 
Block 2         
Cognitions cluster  
(1 vs 2) 
-3.256 -.405 -4.056 <.001 -2.692 -.360 -2.874 .006 
Block 3         
CCQ Reflect/relaxation 
 
.289 .246 1.723 .090 .501 .454 2.543 .014 
CCQ Positive focus 
 
-.760 -.474 -3.908 <.001 -.277 -.193 -1.229 .225 
CCQ Diversion 
 
-.040 -.026 -.193 .848 -.402 -.279 -1.582 .120 
CCQ Planning 
 
-.040 -.026 -.193 .848 .046 .032 .204 .839 
Constant 15.565  4.280 <.001 6.642  1.554 .127 
